Filing Details
- Accession Number:
- 0001062993-18-003579
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-08-29 17:51:13
- Reporting Period:
- 2018-08-23
- Accepted Time:
- 2018-08-29 17:51:13
- Original Submission Date:
- 2018-08-27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375378 | Paul Gitman | C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2018-08-23 | 5,425 | $51.27 | 46,400 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2018-08-24 | 6,400 | $51.09 | 40,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The selling price of $51.2748 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.25 to $52.445. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This amendment is being provided to report the price range of the transactions in connection with the weighted average sale price reported on this line.
- The selling price of $51.0878 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $50.24 to $51.52. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This amendment is being provided to report the price range of the transactions in connection with the weighted average sale price reported on this line.
Billionaire Hedge Funds
